ATE500836T1 - Adrenomedullin und adrenomedullin-bindungsprotein zur ischämie/reperfusionsbehandlung - Google Patents

Adrenomedullin und adrenomedullin-bindungsprotein zur ischämie/reperfusionsbehandlung

Info

Publication number: ATE500836T1
Authority: AT; Austria
Prior art keywords: adrenomedullin; ischemia; binding protein; mammal; reperfusion treatment
Prior art date: 2004-03-31

Application number

AT05732325T

Other languages

English (en)

Inventor

Ping Wang

Original Assignee

The Feinstein Inst Medical Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-31

Filing date

2005-03-30

Publication date

2011-03-15

2005-03-30 Application filed by The Feinstein Inst Medical Res filed Critical The Feinstein Inst Medical Res

2011-03-15 Application granted granted Critical

2011-03-15 Publication of ATE500836T1 publication Critical patent/ATE500836T1/de

Links

102000004379 Adrenomedullin Human genes 0.000 title abstract 4
101800004616 Adrenomedullin Proteins 0.000 title abstract 4
ULCUCJFASIJEOE-NPECTJMMSA-N adrenomedullin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H]1C(N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)[C@@H](C)O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 ULCUCJFASIJEOE-NPECTJMMSA-N 0.000 title abstract 4
208000028867 ischemia Diseases 0.000 title 1
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
230000010410 reperfusion Effects 0.000 title 1
241000124008 Mammalia Species 0.000 abstract 4
206010063837 Reperfusion injury Diseases 0.000 abstract 2
208000027418 Wounds and injury Diseases 0.000 abstract 2
230000006378 damage Effects 0.000 abstract 2
208000014674 injury Diseases 0.000 abstract 2
208000012947 ischemia reperfusion injury Diseases 0.000 abstract 2
101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Zoology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Marine Sciences & Fisheries (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AT05732325T 2004-03-31 2005-03-30 Adrenomedullin und adrenomedullin-bindungsprotein zur ischämie/reperfusionsbehandlung ATE500836T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55793504P	2004-03-31	2004-03-31
PCT/US2005/010822 WO2005097172A2 (en)	2004-03-31	2005-03-30	Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment

Publications (1)

Publication Number	Publication Date
ATE500836T1 true ATE500836T1 (de)	2011-03-15

Family

ID=35125617

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05732325T ATE500836T1 (de)	2004-03-31	2005-03-30	Adrenomedullin und adrenomedullin-bindungsprotein zur ischämie/reperfusionsbehandlung

Country Status (8)

Country	Link
US (1)	US9101593B2 (de)
EP (1)	EP1742651B1 (de)
JP (1)	JP4914344B2 (de)
AT (1)	ATE500836T1 (de)
AU (1)	AU2005231395B2 (de)
CA (1)	CA2562957C (de)
DE (1)	DE602005026794D1 (de)
WO (1)	WO2005097172A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8703693B2 (en)	2004-03-31	2014-04-22	The Feinstein Institute For Medical Research	Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment
ATE500836T1 (de)	2004-03-31	2011-03-15	The Feinstein Inst Medical Res	Adrenomedullin und adrenomedullin-bindungsprotein zur ischämie/reperfusionsbehandlung
JP4830093B2 (ja) *	2005-04-08	2011-12-07	国立大学法人宮崎大学	非細菌性の炎症性疾患の予防又は治療剤
AU2012315586B2 (en) *	2011-09-29	2017-07-20	Mayo Foundation For Medical Education And Research	Aromatic-cationic peptides and methods for using same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2774769B2 (ja) *	1993-04-26	1998-07-09	賢治寒川	アドレノメデュリン
US5679546A (en) *	1993-09-24	1997-10-21	Cytomed, Inc.	Chimeric proteins which block complement activation
GB9624731D0 (en)	1996-11-28	1997-01-15	Univ Leicester	Complement inhibitor
US6620615B1 (en) *	1999-04-23	2003-09-16	Curagen Corporation	G-protein coupled receptor—encoding nucleic acids
DE60025008T2 (de)	1999-09-10	2006-09-14	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Bestimmung von adrenomedullin-bindenden proteinen
US6864237B2 (en) *	2002-05-17	2005-03-08	Ping Wang	Treatment of shock using adrenomedullin and adrenomedullin binding protein-1
US6884781B2 (en)	2003-05-16	2005-04-26	Ping Wang	Treatment of shock using adrenomedullin binding protein-1
US20080051315A1 (en)	2003-12-11	2008-02-28	Eric Kandel	Grp Receptor-Related Methods for the Treating and Preventing Fear-Related Disorders
US8703693B2 (en)	2004-03-31	2014-04-22	The Feinstein Institute For Medical Research	Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment
ATE500836T1 (de)	2004-03-31	2011-03-15	The Feinstein Inst Medical Res	Adrenomedullin und adrenomedullin-bindungsprotein zur ischämie/reperfusionsbehandlung
WO2006124770A2 (en)	2005-05-13	2006-11-23	The Feinstein Institute For Medical Research	Treatment of sepsis and inflammation with alpha2a adrenergic antagonists
CA2608271C (en)	2005-05-13	2016-01-19	The Feinstein Institute For Medical Research	Milk fat globule epidermal growth factor-factor viii and sepsis
WO2009064448A1 (en)	2007-11-15	2009-05-22	The Feinstein Institute For Medical Research	Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using mfg-e8
US8324151B2 (en)	2007-11-20	2012-12-04	The Feinstein Institute For Medical Research	Treatment of sepsis and septic shock using ghrelin and growth hormone

2005
- 2005-03-30 AT AT05732325T patent/ATE500836T1/de not_active IP Right Cessation
- 2005-03-30 WO PCT/US2005/010822 patent/WO2005097172A2/en not_active Ceased
- 2005-03-30 JP JP2007506527A patent/JP4914344B2/ja not_active Expired - Fee Related
- 2005-03-30 CA CA2562957A patent/CA2562957C/en not_active Expired - Fee Related
- 2005-03-30 DE DE602005026794T patent/DE602005026794D1/de not_active Expired - Lifetime
- 2005-03-30 AU AU2005231395A patent/AU2005231395B2/en not_active Ceased
- 2005-03-30 EP EP05732325A patent/EP1742651B1/de not_active Expired - Lifetime
2014
- 2014-02-28 US US14/193,284 patent/US9101593B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP2007537160A (ja)	2007-12-20
EP1742651A2 (de)	2007-01-17
AU2005231395B2 (en)	2011-06-16
JP4914344B2 (ja)	2012-04-11
WO2005097172A3 (en)	2006-03-30
AU2005231395A1 (en)	2005-10-20
DE602005026794D1 (de)	2011-04-21
EP1742651B1 (de)	2011-03-09
EP1742651A4 (de)	2009-08-05
US9101593B2 (en)	2015-08-11
CA2562957A1 (en)	2005-10-20
US20140342988A1 (en)	2014-11-20
CA2562957C (en)	2013-05-21
WO2005097172A2 (en)	2005-10-20

Legal Events

Date	Code	Title	Description
2011-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
NO20054988D0 (no)	2005-10-26	Preparater og metoder for behandling av cancer
MX2009006466A (es)	2009-06-26	Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
PL2601961T3 (pl)	2019-05-31	Kompozycje zawierające LAG-3 i terapeutyczne przeciwciała oraz ich zastosowania w leczeniu raka
PT1976886E (pt)	2015-03-09	Meios e processos para o tratamento de doenças tumorais
SG158112A1 (en)	2010-01-29	Hepatocyte growth factor (hgf) binding proteins
ZA200708026B (en)	2008-11-26	Anti-CTLA4 antibody and indolinone combination therapy for treatment of cancer
TW200612918A (en)	2006-05-01	Lonidamine analogs
WO2009079585A3 (en)	2009-12-30	Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins
NO20081842L (no)	2008-07-08	Fremgangsmåter og sammensetninger for anvendelse ved behandling av pasienter med autoantistoff-positive sykdommer
EP1737482A4 (de)	2010-09-15	Zusammensetzungen und verfahren zur behandlung von krankheiten
ZA200705297B (en)	2009-01-28	Methods and compositions for treating amyloid related diseases
EP2166845A4 (de)	2012-08-01	Alpha-connexin-c-terminale (act) peptide für die behandlung der altersbedingten makulardegeneration
NO20072543L (no)	2007-07-13	Anti-cancer-behandling
EP1605847A4 (de)	2008-02-27	Gegen antikörper gerichtete photodynamische therapie
DE602005015439D1 (de)	2009-08-27	Intravitreale implantate in verbindung mit photodynamischer therapie zur verbesserung der sehkraft
EP2012798A4 (de)	2009-11-04	Verwendung von inositol-tripyrophosphat bei der behandlung von tumoren und erkrankungen
GB0426255D0 (en)	2004-12-29	Improvements in and relating to products for skin treatment
DE60324431D1 (de)	2008-12-11	Derivate des 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazols als antagonisten des gonadotropin freisetzenden hormons (gnrh) zur anwendung in de behandlung von geschlechtshormonellen erkrankungen, wie prostata- oder gebahrmutterkrebs
EP2101799A4 (de)	2010-11-17	Verwendung von anbolika, anti-katabolischen mitteln, antioxidantien und analgetika zum schutz, zur behandlung und zur reparatur von bindegeweben bei mensch und tier
WO2005030928A3 (en)	2006-02-23	PORCINE INVARIANT CHAIN PROTEIN, FULL LENGTH cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
EP1696933A4 (de)	2007-06-20	Zusammensetzungen und verfahren zur verabreichung von tubulin-bindenden mitteln zur behandlung von augenkrankheiten
ATE500836T1 (de)	2011-03-15	Adrenomedullin und adrenomedullin-bindungsprotein zur ischämie/reperfusionsbehandlung
ATE511401T1 (de)	2011-06-15	Kombinierte gentherapie zur behandlung makroskopischer glioma
ZA200708372B (en)	2008-12-31	KIM-1 antibodies for treatment of Th2-mediated conditions
ATE469659T1 (de)	2010-06-15	Stibogluconate-natrium und il-2 zur krebsbehandlung